Drug
LAM561
LAM561 is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
75%
Ph phase_2
1
25%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
recruiting125%
active_not_recruiting125%
completed250%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruitingphase_2
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922
recruitingphase_1
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
NCT04299191
completedphase_1
A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
NCT03867123
completedphase_1
A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours
NCT01792310
Clinical Trials (4)
Showing 4 of 4 trials
NCT04250922Phase 2
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04299191Phase 1
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
NCT03867123Phase 1
A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
NCT01792310Phase 1
A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4